| Strain Descriptor |
Strain Summary |
Genotype |
Phenotype |
| AX1 | axenic strain isolated by Sussman and used by Watts and Ashworth to generate AX2 (1977); this strain has been lost. | axeA, axeB | |
| AX2 | Yukako Asano lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Devreotes Lab strain, axenic | axeA2, axeB2, axeC2 | |
| AX2 | Devreotes Lab strain, axenic | axeA2, axeB2, axeC2 | |
| AX2 | Robert Insall lab strain | axeA2, axeB2, axeC2 | |
| AX2 | Lab strain from Margaret Clarke. | axeA2, axeB2, axeC2 | axe, wt |
| AX2 | Peter Newell lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Salvo Bozzaro lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Thomas Winckler lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Barrie Coukell lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Akiko Oohata lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Rob Kay lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Gerry Weeks lab strain. Deposited twice (6/28/05 and 10/7/08). | axeA2, axeB2, axeC2 | axe, wt |
| AX2 | Rob Insall lab strain via G. Weeks lab; axenic | axeA2, axeB2, axeC2 | axe, wt |
| AX2 | Mineko Maeda lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Tom Egelhoff lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Tamao Saito lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Yasuo Maeda lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Derrick Brazill lab strain; axenic | axeA2.axeB2, axeC2 | axe,wt |
| AX2 | Kees Weijer lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Parental of sGC- | axeA2, axeB2, axeC2 | axe,wt |
| AX2 | Jeff Williams lab strain (originally from Gerisch); axenic | axeA2, axeB2, axeC2 | axe, wt |
| AX2 | generic axenic strain, used for curation of parental strains when the specific AX2 is not available | axeA2, axeB2, axeC2 | axe |
| AX2 | Jonathan Chubb axenic lab strain | axeA2, axeB2, axeC2 | axe |
| AX2 | AX2 strain from the laboratory of Terry OHalloran. | axeA2, axeB2, axeC2 | axe |
| AX2 | Lab strain of Diane Barber. | axeA2, axeB2, axeC2 | axe |
| AX2 | Tian Jin lab strain | axeA2, axeB2, axeC2 | |
| AX2 | Devreotes Lab strain, axenic | axeA2, axeB2, axeC2 | |
| AX2 | Tian Jin, Carol Parent lab strain, axenic | axeA2, axeB2, axeC2 | |
| AX2-2 | Michel Veron lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2-214 | Guenther Gerisch lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2-214 | Wolfgang Nellen lab strain; axenic | axeA2, axeB2, axeC2 | axe,wt |
| AX2ORF | generated by transformation of the pORF + Bsr plasmid (a kind gift of D. Knecht) | axeA2, axeB2, axeC2, rasC-[pORF], bsR | |
| AX3 | generic axenic strain, used for curation of parental strains when the specific AX3 is not available | axeA1, axeB1, axeC1 | axe |
| AX3 | Kees Weijer lab strain; axenic | axeA1, axeB1, axeC1 | axe,wt |
| AX3 | Robert Insall lab strain | axeA1, axeB1, axeC1 | |
| AX3 | Rex Chisholm lab strain; axenic | axeA1, axeB1, axeC1 | axe,wt |
| AX3 | Peter Devreotes lab strain; axenic | axeA1, axeB1, axeC1 | axe,wt |
| AX3 | Daphne Blumberg lab strain; axenic | axeA1, axeB1, axeC1 | axe,wt |
| AX3 | Robert Insall lab strain; axenic | axeA1, axeB1, axeC1 | axe,wt |
| AX3-1 | Rich Kessin lab strain; axenic strain used to develop the FM minimal medium (pmid:17120). Was renamed KAX3 or AX3-K when sent to other laboratories. | axeA1, axeB1, axeC1 | axe,wt |
| Ax3-ampA/lacZ | Ax3 expressing ampA/lacZ reporter construct | axeA1, axeB1, axeC1, [ampA/lacZ], neoR | axe,neoR,wt |
| AX3-ORF+ | AX3 containing integrated copied of the Ddp20RF gene, which allows replication of ori-containing plasmids. | axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+ | axe, wt |
| AX3-ORF+ | AX3 containing integrated copied of the Ddp20RF gene, which allows replication of ori-containing plasmids.
Parental strain for sgkA and sglA overexpressors. | axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+ | axe, wt |
| Ax3-pspD/lacZ (Ax3-PL3Gal) | Ax3 containing prespore pspD/lacZ reporter gene | axeA1, axeB1, axeC1, [PL3/lacZ], neoR | axe,neoR,wt |
| AX3-RC3 | Dave Soll strain (clone of AX3) | axeA1, axeB1, axeC1 | axe |
| AX3.1 | a subclone of the AX3 wild-type strain, chosen for its ability to form fruiting bodies upon starvation and its morphology and behavior during chemotactic assays | axeA1, axeB1, axeC1 | |
| AX4 | Leandro Sastre lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe, wt |
| AX4 | AX4 strain from the Thompson lab that is the parent of GWDI strains. A different isolate of that strain is being sequenced. | axeA1, axeB1, axeC1 | |
| AX4 | Bill Loomis lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe,wt |
| AX4 | Chris Thompson lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | |
| AX4 | Steve Alexander lab strain; axenic; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe,wt |
| AX4 | Gad Shaulsky lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe,wt |
| AX4 | Derrick Brazill lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe,wt |
| AX4 | Adam Kuspa lab strain; axenic; clone of AX3 sent to Loomis by Kessin; reported to have higher transformation efficiency than AX3; strain that was sequenced and that is annotated in dictyBase. | axeA1, axeB1, axeC1 | |
| AX4 | generic axenic strain, used for curation of parental strains when the specific AX4 is not available. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe, wt |
| AX4 | Escalante lab strain; axenic strain, a different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | wt, axe |
| AX4 | Lab strain of Richard Gomer at Rice University. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1, axeC1 | axe, wt |
| AX4 #293 | Strain record created from dicty_Life data. A different isolate of that strain is being sequenced, AX4 | axeA1, axeB1 axeC1 | |
| AX4/ura- | pyr56-null strain with Uracil auxotrophy and resistance to 5FOA | axeA1, axeB1, axeC1, pyr5-6-[pDIV1], ura- | |
| AX4/[tagB]:lacZ | lacZ tagged
neomycin resistant | neoR, axeA1, axeB1, axeC1, chtC-, [tagB/lacZ] | |
| axeB- | axeB null mutant in DdB | DdB, axeB-, [pBluescript2 KS+-V18-tn5], neoR | |
| B. agricolaris | non-food bacterium; colonizes Dictyostelium and drives the farming phenomenon; isolated as a symbiont of the wild strain QS159 in May 2008, which was collected from the Mountain Lake Biological Station; optimal growth at 30˚C, week growth at 22˚C and 37˚C, and no growth at 4˚C or 45˚C | wt | |
| B. bonniea | non-food bacterium, colonizes Dictyostelium and drives the farming phenomenon; isolated as a symbiont of the wild strain QS859 in August 2014, which was collected from the Mountain Lake Biological Station; growth at 30˚C, week growth at 22˚C and no growth at 4˚C, 37˚C, or 45˚C | wt | |
| B. hayleyella | non-food bacterium, colonizes Dictyostelium and drives the farming phenomenon; isolated as a symbiont of the wild D.d. strain QS11 in February 2008, which was collected from the Mountain Lake Biological Station; growth at 30˚C, week growth at 22˚C and no growth at 4˚C, 37˚C, or 45˚C | wt | |
| B. subtilis 36.1 | bacterial strain Bacillus subtilis 36.1; biosafety level 1 (USA) | wt | |
| B. subtilis LS-3 | bacterial strain Bacillus subtilis LS-3; biosafety level 1 (USA) | wt | |
| bcas3- | bcas3 null mutant in AX2 | axeA2, axeB2, axeC2, bcas3, [pBcas3-KO], bsR | |
| bpiC- | bpiC null mutant in DH10 | axeA1, axeB1, axeC1, pyr5-6-[pRG24], ura-, bpiC-, [bsRcas], bsR | |
| br-1 | original brown mutant | bwn | brown |
| bzpF- | bzpF mutant in AX4 | axeA1, axeB1, axeC1, bzpF-, [bsR-loxP], bsR | |
| bzpN- | bzpN null mutant | axeA1, axeB2, axeC2, bzpN-, bsR | |
| bzpN-/[act15]:bzpN:GFP | C-terminal fusion of GFP to bzpN under the control of the actin15 promoter expressed in a bzpN null mutant | axeA1, axeB2, axeC2, bzpN-, [act15]:GFP, bsR, neoR | |
| bzpR- | bzpR null mutant | axeA1, axeB1, axeC1, bzpR-, [bsRcas], bsR | |
| c2gapB- | c2gapB null mutant in AX2 | axeA2, axeB2, axeC2, c2gapB-, [bsRcas], bsR | |
| cadA- | cadA mutant in AX4 | axeA1, axeB1, axeC1, cadA-, [pCR2.1-TOPO] | |
| cadA- | cadA null mutant in AX4 | axeA1, axeB1, axeC1, cadA-, [bsR-loxP], bsR | |
| cadA- | cadA null mutant (cell-cell adhesion mutant) | axeA1, axeB1, axeC1, cadA-[pbsr/cadA], bsR | |
| cak1- | cak1 REMI mutant; this gene is on the chr. 2 duplication and both copies have been targeted; the insertion site is 284 bp downstream of the 5 '''' boundary of the 2nd exon; insertion at the upper case DpnII restriction site (GATC) in this sequence: gttatcgtGATCcaaagactc;
get raw sequence data | axeA1, axeB1, axeC1, cak1-, bsR | |
| cap- | Cyclase-associated protein (CAP) mutant; not a null mutant; about 5% left | axeA2, axeB21, axeC2, capA-[CAP-bsr], bsR | axe,bsR |
| cAR1-GFP/RI-9 | cAR1-GFP expressed in RI-9(RI9) | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], carC-[5cAR3ura], ura+, [car1::GFP], neoR | axe, neoR, gfp |
| cAR1-YFP/RI-9 | cAR1-YFP expressed in RI-9(RI9) | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], carC-[5cAR3ura], ura+, [car1::YFP], neoR | axe,neoR |
| carA- | cAR1 null mutant | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], [pMC26-precursor], ura- | axe,agg-,ura- |
| carA- | carA null mutant; control strain for double carA/carC mutant | axeA2, axeB2, axeC2, pyr5-6-[pMYC10], carA-[NPT1], [pRJ648], neoR | agg-,ura+,neoR |
| carA- | cAR1 null mutant | axeA1, axeB1, axeC1, pyr5-6-[pRG24), carA-[pMC25], ura+ | axe, agg-, ura+ |
| carA- | carA null mutant | axeA2, axeB2, axeC2, tsg-2(tsgJ2), carA-[NPT1], neoR | axe,agg-,neoR |
| carA- | cAR1 null mutant in which the pyr56 gene is deleted in order to be able to construct double mutants | axeA2, axeB2, axeC2, tsg-2(tsgJ2), pyr5-6-[pMYC10], carA-[NPT1], neoR | axe, agg-, ura-, neoR |
| carA-/carC- | carA/carC double null mutant | axeA1, axeB1, axeC1, carA-[NPT1], carC-[pRJ648], ura+, neoR | axe,agg-,neoR,ura+,agg- |
| carA-/carC- | carA/carC double null mutant | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], carC-[5cAR3ura], ura+ | axe,agg-,ura+ |
| carA-/carC-/[act15]:carA(261-359;S299A | phosphorylation defective C-terminal fragment of CarA in carA, carC- double null | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], carC-[5cAR3ura], ura+, carA(261-359;S299A, S302G, S303G, S304G, S308A, S324G, S325A, S331A)(369-392;S383A, S385A), [pJK1], neoR | |
| carA-/carC-/[act15]:GFP:gtaC | N-terminal fusion of GFP to gtaC under the control of the act15 promoter expressed in a carA/carC double null mutant | axeA1, axeB1, axeC1, carA-, carC-, [act15:GFP:gtaC], neoR | |
| carA-/carC-/[rasC]:rasC | carA-/carC- double null mutant overexpressing rasC under the control of its own promoter on a multicopy plasmid | axeA1, axeB1, axeC1, carA-, carC-, [rasC]:rasC, neoR | |
| carA-/[act15]:gpbA:YFP | YFP-tagged gpaB expressed in carA null | axeA2, axeB2, axeC2, tsg-2(tsgJ2), carA-[NPT1], gpbA:YFP, [GΒ-YFP], neoR | |
| carA-/[unk]:carA(261-359;S299A | phosphorylation defective C-terminal fragment of CarA, tagged with eYFP, expressed in carA null cells | axeA1, axeB1, axeC1, pyr5-6-[pRG24], carA-[pMC25], [pMC26-precursor], carA(261-359;S299A, S302G, S303G, S304G, S308A, S324G, S325A, S331A)(369-392;S383A, S385A):eYFP, neoR, ura- | |
| carB- | carB- null mutant | axeA1, axeB1, axeC1, pyr5-6-[PYR5-6-SalI-linker], thy-[PYR5-6-THY1], carB-, ura+, thy+ | |
| carB- | cAR2 null mutant | axeA1, axeB1, axeC1, cycA1, tsgA1, acrD369, ebrB364, sprH351, manA1, tmpA600, carB-[carB-thy], thy+ | axe |
| carB- | carB null mutant | axeA1, axeB1, axeC1, cycA1, tsgA1, acrD369, ebrB364, sprH351, manA1, tmpA600, carB-[carB-thy], thy+ | axe, cycR**, tsg**, acrR**, ebR, agg- |
| carB-/[act15]:carB | carB-null strain expressing carB from the extrachromosomal vector pJK1 | axeA1, axeB1, axeC1, cycA1, tsgA1, acrD369, ebrB364, sprH351, manA1, tmpA600, carB-[carB-thy], thy+, [pJK1::gCAR2], neoR | axe, neoR |
| carB-/[act15]:GFP | cAR2-null mutant expressing GFP from the actin 15 promoter. | axeA1, axeB1, axeC1, cycA1, tsgA1, acrD369, ebrB364, sprH351, manA1, tmpA600, carB-[carB-thy], thy+, [act15]:GFP, neoR | axe, cycR, tsg, neoR |
| carB-/[carB]:lacZ | β-Galactosidase expression under control of the cAR2 promoter in a cAR2-null strain. | axeA1, axeB1, axeC1, cycA1, tsgA1, acrD369, ebrB364, sprH351, manA1, tmpA600, carB-[carB-thy], thy+, [carB::lacZ], neoR | axe, neoR, cycR, metR, ebR, tsg |
